Autophagy is an evolutionarily conserved pathway in which cytoplasmic contents are degraded and recycled. This study found that submicromolar concentrations of urolithin A, a major polyphenol metabolite, induced autophagy in SW620 colorectal cancer (CRC) cells. Exposure to urolithin A also dose-dependently decreased cell proliferation, delayed cell migration, and decreased matrix metalloproteinas-9 (MMP-9) activity. In This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
| INTRODUCTION
Colorectal cancer (CRC) is the second most common gastrointestinal cancer worldwide, 1 and preventing tumor cell metastasis is important for prolonging patient survival. 2 In recent years, the relationship between cancer and autophagy has been extensively studied, [3] [4] [5] [6] [7] and autophagy can promote or inhibit tumor metastasis under different circumstance. Autophagy may exert an inhibitory effect in early stage tumors, reducing invasion, and metastasis.
During later stages, autophagy promotes metastasis by supporting cell survival following ECM detachment and preventing cell dormancy upon ECM reattachment. 8, 9 Autophagy is already known to play an important role in CRC progression. 10 Another key step in the process of metastasis is basement membrane and extracellular matrix degradation. 11 Matrix metalloproteinase (MMPs) upregulation also promotes metastasis. [12] [13] [14] Polyphenols provide a wide range of anti-carcinogenic health benefits. [15] [16] [17] [18] [19] [20] [21] [22] However, polyphenol absorption is reportedly very low.
Urolithins are the major metabolites of polyphenols in the gut. [23] [24] [25] We isolated and purified urolithins from the intestinal metabolites of pomegranate ellagitannins by high-speed counter-current chromatography. 26 Urolithins can be absorbed by multiple tissue types and can suppress tumorigenesis, 27 oxidation, 28 inflammation, [29] [30] [31] 
| Detection of apoptosis
Apoptosis was evaluated using a flow cytometer with Annexin V-FITC and PI staining. Briefly, SW620 cells were cultivated in six-well plates.
At the end of the incubation, cells were suspended in PBS three times, 
| Measurement of autophagy
Autophagy was monitored using the Cyto-ID TM Autophagy Detec- 
| Statistical analysis
All experiments were repeated at least three times. Data are reported as means ± SD. Statistical differences between groups were analyzed using the Student's t-test or the Student-Neuman-Keuls multiple comparison test. Differences were considered statistically significant at P < 0.05.
3 | RESULTS
| Urolithin A inhibits SW620 cell proliferation and metastasis
To examine the effects of urolithin A on SW620 colon cancer cell proliferation, exponentially growing cells were exposed to various concentrations of urolithin A for 24 h, and proliferation was measured via MTT assay. A dose-dependent proliferation decrease was observed in treated cells ( Figure 1A, B) . Exposure to high urolithin A concentrations (≥15 µM) produced the strongest anti-proliferative effects, probably by promoting cell death.
We next examined the effects of urolithin A on SW620 cell mobility via the chamber migration assay. The number of cells that migrated across the wound decreased by 35.2% (n = 3, P < 0.01)
following treatment with 0.05 µM urolithin A for 48 h ( Figure 1C ), and cell migration was delayed up to 21.3% (n = 3, P < 0.05) ( Figure   1D ).
MMP-9, which degrades the basement membrane and extracellular matrix, is enhanced in various malignant tumors and promotes invasion and metastasis. Treatment of SW620 cells with urolithin A (0.05 µM) strongly decreased MMP-9 activity in these cells (reduced by 29.8%, n = 3, P < 0.01) ( Figure 1E ). Figures 3A and 3C) . However, at concentrations ranging from 1.5 to 15 uM, urolithin did not induce apoptosis. These results suggest that micromolar urolithin A induces both autophagy and apoptosis approximately 24 h after treatment.
| Urolithin A inhibits cell cycle progression in SW620 cells
Cell cycle distribution profiles for urolithin A-exposed SW620 cells
were assessed via flow cytometry. Urolithin A treatment resulted in the progressive accumulation of G2/M phase cells until 24 h (Figures 3B and 3D) . Thus, urolithin A deregulates cell cycle progression and inhibits DNA synthesis in SW620 cells. 
| DISCUSSION
Epidemiological studies suggest that consumption of plantderived foods correlates with reduced cancer mortality. [40] [41] [42] The anticancer effects of polyphenols are reportedly caused by FIGURE 4 Effect of autophagy, apoptosis inhibition on urolithin A-mediated cell proliferation and anti-metastasis activity. Cells were pretreated with pharmacological autophagy inhibitors (Atg5 siRNA, 3-MA, bafilomycin, and chloroquine), then incubated with or without urolithin A for 24 h. Cell proliferation was measured using MTT assay (A) and MMP-9 activity was determined by MMP assay (B). Cells were pretreated without (a) or with (b) 0.5 mM 3-MA for 1 h, then incubated with 1.5 µM urolithin A for 48 h, cells were seeded above transwell chamber membranes. After 4 h, membrane bottoms were stained with crystal violet and photographs were taken (×200 magnification) to assess cell invasion (C). Cells were pretreated with 20 µM Z-VAD-FMK for 1 h, then incubated with or without urolithin A for 24 h. Cell proliferation was measured using MTT assay (D) and MMP-9 activity was determined by MMP assay (E) and caspase-3 activity was determined by caspase-3 assay (F) **P < 0.05 represents significant difference from the control group. #P < 0.05 represents significant difference from the urolithin A treatment group. Data represent means ± S.D. for one experiment performed in triplicate apoptosis induction via cell survival pathways. 43 49, 50 Our studies suggested that the anticancer effects of urolithin A may result, at least in part, from autophagy induction at both lower and higher concentrations, and apoptosis at higher concentrations. Of note, the urolithin A concentrations that triggered autophagy were consistent with those found in the intestine, showing that dietary polyphenols play important roles in body functions.
Recently, studies showed that autophagy and MMP-9 were correlated and autophagy may promote MMP-9 induction. [51] [52] [53] In the current study, we found that both autophagy and apoptosis were induced in response to urolithin A treatment, but MMP-9 was reduced. Autophagy plays a complex role in tumorigenesis; at early stages of tumor formation, autophagy has been shown to be oncosuppressive. However, autophagy seems to be required for the progression of adenomas to carcinomas at later stages of disease. 
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